Publications by authors named "M Miegeville"

Article Synopsis
  • * The overall incidence was 0.37 cases per 1,000 admissions, with higher rates in hematology (6.65) and intensive care units (2); central venous catheter use and antibiotic exposure were common risk factors.
  • * Candida albicans was the most common species identified (51.8%), and the study found a 12-week mortality rate of 30.9%, emphasizing the need for antifungal susceptibility testing due to some resistance in isolates.
View Article and Find Full Text PDF

Several and often combined mechanisms can lead to acquired azole resistance in Candida albicans and subsequent therapeutic failure. The aim of this study was to provide a complete overview of the molecular basis of azole resistance in a set of six C. albicans clinical isolates recovered from patients who failed azole therapy.

View Article and Find Full Text PDF

Pneumocystis jirovecii pneumonia (PCP) is an opportunistic infection with airborne transmission and remains a major cause of respiratory illness among immunocompromised individuals. In recent years, several outbreaks of PCP, occurring mostly in kidney transplant recipients, have been reported. Currently, multilocus sequence typing (MLST) performed on clinical samples is considered to be the gold standard for epidemiological investigations of nosocomial clusters of PCP.

View Article and Find Full Text PDF

Objectives: To determine the mechanisms responsible for fluconazole resistance in two Candida albicans isolates (CAAL2 and CAAL76) recovered from two hospitalized patients after fluconazole prophylaxis.

Methods: MICs of fluconazole and voriconazole were determined by the broth microdilution method (CLSI M27-A3), and by Etest(®) for amphotericin B. RNA expression levels of CDR1, MDR1 and ERG11 were determined by RT-PCR.

View Article and Find Full Text PDF

Objectives: Triazole resistance in Aspergillus fumigatus due to a single azole resistance mechanism (TR/L98H) is increasingly reported in European countries. Data from patients with cystic fibrosis (CF) are limited. Our study aimed to investigate the prevalence and molecular mechanisms of azole resistance in A.

View Article and Find Full Text PDF